当前位置:首页 - 行情中心 - 心脉医疗(688016) - 财务分析 - 现金流量表

心脉医疗

(688016)

  

流通市值:122.51亿  总市值:122.51亿
流通股本:1.23亿   总股本:1.23亿

现金流量表

报告期2025-12-312025-09-302025-06-302025-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,369,647,675.84854,974,998.51607,420,761.94161,880,996.15
  收到的税费返还501,911.56999,420.29501,911.56501,911.56
  收到其他与经营活动有关的现金84,787,483.59105,822,276.481,284,158.2128,349,868.44
  经营活动现金流入小计1,454,937,070.99961,796,695.2689,206,831.71190,732,776.15
  购买商品、接受劳务支付的现金284,442,393.51143,784,792.1190,445,596.4238,785,695.98
  支付给职工以及为职工支付的现金283,610,959.65202,134,285.92131,979,768.5667,615,649.94
  支付的各项税费178,954,504.5151,959,022.8988,304,922.0722,209,660.21
  支付其他与经营活动有关的现金134,865,258.08100,716,945.9259,873,223.4622,093,985.72
  经营活动现金流出小计881,873,115.74598,595,046.84370,603,510.51150,704,991.85
  经营活动产生的现金流量净额573,063,955.25363,201,648.36318,603,321.240,027,784.3
二、投资活动产生的现金流量:
  收回投资收到的现金4,930,000,0002,925,000,0002,135,000,000460,000,000
  取得投资收益收到的现金15,976,849.839,168,253.086,974,089.84488,888.89
  投资活动现金流入小计4,945,976,849.832,934,168,253.082,141,974,089.84460,488,888.89
  购建固定资产、无形资产和其他长期资产支付的现金303,033,026.27215,020,875.92128,993,857.06100,401,265.38
  投资支付的现金5,030,000,0004,090,000,0002,525,000,0001,520,000,000
  投资活动现金流出小计5,333,033,026.274,305,020,875.922,653,993,857.061,620,401,265.38
  投资活动产生的现金流量净额-387,056,176.44-1,370,852,622.84-512,019,767.22-1,159,912,376.49
三、筹资活动产生的现金流量:
  取得借款收到的现金126,000,000126,000,000126,000,000126,000,000
  筹资活动现金流入小计126,000,000126,000,000126,000,000126,000,000
  偿还债务支付的现金140,000,000140,000,000140,000,000-
  分配股利、利润或偿付利息支付的现金201,834,960.143,558,034.843,558,034.8685,125
  支付其他与筹资活动有关的现金134,083,628.72122,755,433.4485,804,482.274,883,104.15
  筹资活动现金流出小计475,918,588.82306,313,468.24269,362,51775,568,229.15
  筹资活动产生的现金流量净额-349,918,588.82-180,313,468.24-143,362,51750,431,770.85
四、汇率变动对现金及现金等价物的影响-2,871,180.32255,712.02890,545.98-10,900,800.36
五、现金及现金等价物净增加额-166,781,990.33-1,187,708,730.7-335,888,417.04-1,080,353,621.7
  加:期初现金及现金等价物余额2,058,831,245.142,058,831,245.142,058,831,245.142,058,831,245.14
  期末现金及现金等价物余额1,892,049,254.81871,122,514.441,722,942,828.1978,477,623.44
补充资料:
  净利润554,659,959.66-310,624,892.41-
  资产减值准备9,271,248.76-3,850,457.37-
  固定资产和投资性房地产折旧13,593,988.86-7,468,090.14-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧13,593,988.86-7,468,090.14-
  无形资产摊销53,408,929.34-24,281,615.02-
  长期待摊费用摊销10,651,037.81-5,443,237.27-
  处置固定资产、无形资产和其他长期资产的损失--3,956.26-
  固定资产报废损失89,021---
  公允价值变动损失-367,945.21---
  财务费用6,882,102.44-1,647,252.81-
  投资损失-15,976,849.83--7,659,856.97-
  递延所得税-11,348,913.81--74,456.82-
  其中:递延所得税资产减少-5,372,460.42--3,278,274.31-
    递延所得税负债增加-5,976,453.39-3,203,817.49-
  存货的减少-14,369,865.11-45,949,631.38-
  经营性应收项目的减少90,927,824.01--159,226,028.01-
  经营性应付项目的增加-159,007,774.59-65,634,222.31-
  其他14,287,357.8-8,236,070.76-
  不涉及现金收支的投资和筹资活动金额其他项目1,220,071.08---
  现金的期末余额1,892,049,254.81-1,722,942,828.1-
  减:现金的期初余额2,058,831,245.14-2,058,831,245.14-
  现金及现金等价物的净增加额-166,781,990.33--335,888,417.04-
公告日期2026-03-312025-10-302025-08-272025-04-30
审计意见(境内)标准无保留意见
TOP↑